- Johnson & Johnson (JNJ) has accepted Carlyle's (CG) $4.15B binding offer for J&J's Ortho-Clinical Diagnostics (OCD) business.
- J&J accepted the proposal, which the private-equity firm made in January, after consultation with the relevant works councils and trade unions.
- J&J expects the deal to close toward the middle of the year. (PR)
at Zacks.com (Nov 17, 2014)